Bone marrow transplantationLetter

21 Feb 2025

COVID-19 prior to hematopoietic stem cell transplantation increases the risk of acute graft-versus-host disease but does not affect overall mortality.

No abstract available

COI Statement

Competing interests: The authors declare no competing interests.

References:

  • Randi BA, Higashino HR, Silva VPD, Xavier EM, Rocha V, Costa SF. COVID-19 in hematopoietic stem-cell transplant recipients: A systematic review and meta-analysis of clinical characteristics and outcomes. Rev Med Virol. 2023;33:e2483.
  • Piñana JL, Pérez A, Chorão P, Guerreiro M, García-Cadenas I, Solano C, et al. Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances. Transpl Infect Dis. 2023;25:e14117.
  • Oltolini C, Travi G, Mikulska M. The impact of prior COVID-19 on non-infectious endothelial complications following allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2024:ciae307. https://doi.org/10.1093/cid/ciae307 . Online ahead of print.
  • Nimgaonkar I, Yoke LH, Roychoudhury P, Flaherty PW, Oshima MU, Weixler A, et al. Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients With Pre-Cellular Therapy SARS-CoV-2 Infection. Clin Infect Dis. 2024;79:86–95.
  • Shah N, Dahi PB, Ponce DM, Sauter CS, Shaffer BC, Chung DJ, et al. Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection. Transplant Cell Ther. 2022;28:55.e1–.e5.

Article info

Journal issue:

  • Volume: not provided
  • Issue: not provided

Doi:

10.1038/s41409-025-02536-y

Share: